Invictus RG (Singapore)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Invictus RG (Singapore)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-150	Closed	-$21K	–	454
2015 Q3	$21K	Buy	150 +68	+83%	+$9.51K	0.02%	478
2015 Q2	$12K	Sell	82 -672	-89%	-$95.8K	0.01%	540
2015 Q1	$106K	Sell	754 -1,790	-70%	-$276K	0.1%	303
2014 Q4	$377K	Sell	2,544 -756	-23%	-$111K	0.41%	62
2014 Q3	$508K	Buy	3,300 +500	+18%	+$75.3K	0.64%	10
2014 Q2	$393K	Buy	+2,800	New	+$311K	0.41%	50

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Invictus RG (Singapore)'s TARO Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2015, closing a stake of 150 shares — an estimated $21K sold.

Invictus RG (Singapore) first reported a position in TARO in Q2 2014 and held it in 6 quarters. The position peaked at $508K in Q3 2014. 153 funds tracked by Wall St. Rank hold TARO as of Q4 2015.

Invictus RG (Singapore) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 150 Taro Pharmaceutical Industries Ltd. shares in Q4 2015, an estimated $21K.
Invictus RG (Singapore) first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 6 quarters.
Invictus RG (Singapore)'s Taro Pharmaceutical Industries Ltd. position peaked at $508K in Q3 2014.
153 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.